(Q61975096)

English

Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

PhaseⅡ Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Squamous Carcinoma After Failure of Conventional Chemotherapy (English)

0 references

medical condition

carcinoma

0 references

start time

October 2013

0 references

end time

September 2018

0 references

number of participants

50

0 references

clinical trial phase

phase II clinical trial

0 references

research site

Sun Yat-sen University

0 references

research subject recruitment status

unknown

0 references

minimum age

18 year

0 references

maximum age

75 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01973725

0 references

(Q61975096)

Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)